Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boers

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Annals of Surgical Oncology|March 5, 2019
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant TherapyMartine Bloemendal, Wouter W van Willigen, Kalijn F Bol, et al.
Fungal Systematics and Evolution|March 28, 2024
New and Interesting Fungi. 6P W Crous, A Akulov, S Balashov, et al.
Human Mutation|October 31, 2006
Diversity of cystathionine beta-synthase haplotypes bearing the most common homocystinuria mutation c.833T>C: a possible role for gene conversionPetr Vyletal, Jitka Sokolová, David N Cooper, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2021
Survival of stage IV melanoma in Belgium and the NetherlandsK P M Suijkerbuijk, J B A G Haanen, M J Boers-Sonderen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 20, 2023
Health-state utilities in long-term advanced melanoma survivors comparable with the general populationM D Egeler, L V van de Poll-Franse, R Tissier, et al.
Journal of the American Dietetic Association|October 18, 2008
A survey of natural protein intake in Dutch phenylketonuria patients: insight into estimation or measurement of dietary intakeMargreet van Rijn, Jolanda Jansma, Aeltsje Brinksma, et al.
Clinical Nuclear Medicine|December 19, 2023
The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?Bernies van der Hiel, Else A Aalbersberg, Alfons J M van den Eertwegh, et al.
Cell|December 24, 2014
Long-term culture of genome-stable bipotent stem cells from adult human liverMeritxell Huch, Helmuth Gehart, Ruben van Boxtel, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controlsA H Boekhout, A Rogiers, K Jozwiak, et al.
Immuno-Oncology Technology|July 24, 2024
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanomaI A J van Duin, M Schuiveling, L S Ter Maat, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Annals of Surgical Oncology|March 5, 2019
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant TherapyMartine Bloemendal, Wouter W van Willigen, Kalijn F Bol, et al.
Fungal Systematics and Evolution|March 28, 2024
New and Interesting Fungi. 6P W Crous, A Akulov, S Balashov, et al.
Human Mutation|October 31, 2006
Diversity of cystathionine beta-synthase haplotypes bearing the most common homocystinuria mutation c.833T>C: a possible role for gene conversionPetr Vyletal, Jitka Sokolová, David N Cooper, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2021
Survival of stage IV melanoma in Belgium and the NetherlandsK P M Suijkerbuijk, J B A G Haanen, M J Boers-Sonderen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 20, 2023
Health-state utilities in long-term advanced melanoma survivors comparable with the general populationM D Egeler, L V van de Poll-Franse, R Tissier, et al.
Journal of the American Dietetic Association|October 18, 2008
A survey of natural protein intake in Dutch phenylketonuria patients: insight into estimation or measurement of dietary intakeMargreet van Rijn, Jolanda Jansma, Aeltsje Brinksma, et al.
Clinical Nuclear Medicine|December 19, 2023
The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?Bernies van der Hiel, Else A Aalbersberg, Alfons J M van den Eertwegh, et al.
Cell|December 24, 2014
Long-term culture of genome-stable bipotent stem cells from adult human liverMeritxell Huch, Helmuth Gehart, Ruben van Boxtel, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controlsA H Boekhout, A Rogiers, K Jozwiak, et al.
Immuno-Oncology Technology|July 24, 2024
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanomaI A J van Duin, M Schuiveling, L S Ter Maat, et al.
Pageof 13